8-K Announcements
6Material company update
Feb 26, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Feb 4, 2026·SEC
Markel Corporation(MKL)Earnings, Financials & Key Ratios
MKL•NYSE•Insurance & Managed Care
10.9× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryProperty & Casualty InsuranceSub-IndustryReinsurers and hybrid reinsurance groups
AboutMarkel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, Bermuda, the United Kingdom, rest of Europe, Canada, the Asia Pacific, and the Middle East. Its Insurance segment offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind. This segment also offers credit and surety products, and collateral protection insurance products. The company's Reinsurance segment offers transaction, healthcare, and environmental impairment liability; and specialty treaty reinsurance products comprising structured and whole turnover credit, political risk, mortgage and contract, and commercial surety reinsurance programs. Its Markel Ventures segment provides equipment used in baking systems and food processing; portable dredges; over-the-road car haulers and transportation equipment; and laminated oak and composite wood flooring, tube and tank trailers, as well as ornamental plants and residential homes, handbags, and architectural products. This segment also provides consulting, and other types of services to businesses and consumers, including distribution of exterior building products, crane rental, fire protection, and life safety services, management and technology consulting, and retail intelligence services. The company's Other segment provides healthcare, leasing and investment services, as well as operates as an insurance and investment fund manager offering a range of investment products, including insurance-linked securities, catastrophe bonds, insurance swaps, and weather derivatives; and program services. it also manages funds with third parties. Markel Corporation was founded in 1930 and is based in Glen Allen, Virginia.Show more
- Revenue$16.59B-1.0%
- Combined Ratio83.53%+6.7%
- Net Income$2.11B-23.3%
- Return on Equity11.52%-30.8%
- Medical Cost Ratio30.62%-31.4%
- Operating Margin16.47%-24.1%
- Net Margin12.7%-22.6%
- ROA3.62%-40.1%
- Equity / Assets27.72%-24.9%
MKL Key Insights
Markel Corporation (MKL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 83.5% combined ratio
- ✓Strong 5Y profit CAGR of 20.9%
- ✓Strong Piotroski F-Score: 7/9
- ✓Low loss ratio of 30.6%
- ✓Healthy dividend yield of 2.6%
- ✓Share count reduced 2.4% through buybacks
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when MKL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MKL Price & Volume
Markel Corporation (MKL) stock price & volume — 10-year historical chart
Loading chart...
MKL Growth Metrics
Markel Corporation (MKL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years11.94%
5 Years11.47%
3 Years11.98%
TTM7.74%
Profit CAGR
10 Years13.71%
5 Years20.89%
3 Years-
TTM-3.83%
EPS CAGR
10 Years15.02%
5 Years24.92%
3 Years-
TTM2.27%
Return on Capital
10 Years6.04%
5 Years9.23%
3 Years9.53%
Last Year14.89%
MKL Recent Earnings
Markel Corporation (MKL) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
Apr 28, 2026Metric
Actual
Est
EPS
$21.61-18.1%
$26.38
Rev
$2.8B-22.9%
$3.7B
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$34.45+24.7%
$27.62
Rev
$4.2B+15.9%
$3.6B
Q4 2025
Oct 29, 2025Metric
Actual
Est
EPS
$30.90+28.6%
$24.02
Rev
$4.4B+17.0%
$3.7B
Q3 2025
Jul 30, 2025Metric
Actual
Est
EPS
$25.46+2.0%
$24.97
Rev
$4.4B-8.6%
$4.8B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 28, 2026 | $21.61vs $26.38-18.1% | $2.8Bvs $3.7B-22.9% |
| Q1 2026 | Feb 4, 2026 | $34.45vs $27.62+24.7% | $4.2Bvs $3.6B+15.9% |
| Q4 2025 | Oct 29, 2025 | $30.90vs $24.02+28.6% | $4.4Bvs $3.7B+17.0% |
| Q3 2025 | Jul 30, 2025 | $25.46vs $24.97+2.0% | $4.4Bvs $4.8B-8.6% |
Based on last 12 quarters of dataView full earnings history →
MKL Peer Comparison
Markel Corporation (MKL) competitors in Reinsurers and hybrid reinsurance groups — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 RLI | 4.88B | 53.09 | 12.18 | 6.33% | 20.8% | 22% | 0.06 | |
 ERIE | 10.21B | 221.14 | 20.82 | 7.17% | 13.2% | 25.03% | ||
 HCI | 2.13B | 163.63 | 6.58 | 20.21% | 32.64% | 30.81% | 0.06 | |
 KMPR | 1.47B | 25.03 | 10.93 | 3.62% | 0.89% | 1.53% | 0.38 | |
 WRB | 25.16B | 67.18 | 15.10 | 7.82% | 12.1% | 18.86% | 0.29 | |
 RNR | 12.91B | 299.17 | 5.28 | 9.45% | 26.93% | 16.59% | 0.12 | |
 ACGL | 32.48B | 91.18 | 7.85 | 14.27% | 22.07% | 19.02% | 0.11 | |
 AXS | 7.45B | 100.99 | 8.18 | 9.05% | 16.18% | 16.93% | 0.23 |
Compare MKL vs Peers
Markel Corporation (MKL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MKL Income Statement
Markel Corporation (MKL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.06B | 6.95B | 9.52B | 9.64B | 12.92B | 11.81B | 15.71B | 16.75B | 16.59B | 16.57B |
Revenue Growth % | 8.09% | 14.59% | 36.98% | 1.26% | 34.02% | -8.55% | 33.02% | 6.6% | -0.96% | 7.74% |
Medical Costs & Claims | 4.22B | 4.3B | 4.67B | 6.26B | 7.03B | 8.41B | 7.63B | 7.48B | 5.08B | 6.39B |
Medical Cost Ratio % | 69.56% | 61.94% | 49.03% | 64.91% | 54.38% | 71.17% | 48.57% | 44.64% | 30.62% | 38.56% |
Gross Profit | 1.85B▲ 0% | 2.64B▲ 43.3% | 4.85B▲ 83.5% | 3.38B▼ 30.3% | 5.89B▲ 74.2% | 3.41B▼ 42.2% | 8.08B▲ 137.3% | 9.27B▲ 14.8% | 11.51B▲ 24.1% | 10.18B▲ 0% |
Gross Margin % | 30.44% | 38.06% | 50.97% | 35.09% | 45.62% | 28.83% | 51.43% | 55.36% | 69.38% | 61.44% |
Gross Profit Growth % | -21.83% | 43.27% | 83.46% | -30.3% | 74.25% | -42.21% | 137.29% | 14.75% | 24.12% | - |
Operating Expenses | 1.76B | 2.65B | 2.57B | 2.38B | 2.76B | 3.56B | 5.43B | 5.64B | 8.78B | 7.88B |
OpEx / Revenue % | 29% | 38.17% | 26.96% | 24.71% | 21.39% | 30.11% | 34.54% | 33.64% | 52.91% | 47.55% |
Depreciation & Amortization | 203.87M | 227.85M | 269.24M | 307.07M | 336.39M | 309.45M | 319.73M | 342.36M | 0 | 138.79M |
Combined Ratio % | 98.56% | 100.11% | 75.99% | 89.62% | 75.77% | 101.28% | 83.11% | 78.28% | 83.53% | 86.11% |
Operating Income | 87.3M▲ 0% | -7.86M▼ 109.0% | 2.29B▲ 29200.0% | 1B▼ 56.2% | 3.13B▲ 212.8% | -151.57M▼ 104.8% | 2.65B▲ 1850.9% | 3.64B▲ 37.1% | 2.73B▼ 24.9% | 2.3B▲ 0% |
Operating Margin % | 1.44% | -0.11% | 24.01% | 10.38% | 24.23% | -1.28% | 16.89% | 21.72% | 16.47% | 13.89% |
Operating Income Growth % | -86.14% | -109% | 29200.04% | -56.23% | 212.84% | -104.84% | 1850.86% | 37.08% | -24.88% | - |
EBITDA | 291.17M | 219.99M | 2.56B | 1.31B | 3.47B | 157.88M | 2.97B | 3.98B | 2.94B | 2.49B |
EBITDA Margin % | 4.8% | 3.17% | 26.84% | 13.56% | 26.83% | 1.34% | 18.92% | 23.76% | 17.71% | 15.03% |
Interest Expense | 132.45M | 154.21M | 171.69M | 177.58M | 183.58M | 196.06M | 185.08M | 204.3M | 205.91M | 204.66M |
Non-Operating Income | -132.45M | -154.21M | -171.69M | -177.58M | -183.58M | -196.06M | -185.08M | -204.3M | -205.91M | -153.77M |
Pretax Income | 87.3M▲ 0% | -7.86M▼ 109.0% | 2.29B▲ 29200.0% | 1B▼ 56.2% | 3.13B▲ 212.8% | -151.57M▼ 104.8% | 2.65B▲ 1850.9% | 3.64B▲ 37.1% | 2.73B▼ 24.9% | 2.31B▲ 0% |
Pretax Margin % | 1.44% | -0.11% | 24.01% | 10.38% | 24.23% | -1.28% | 16.89% | 21.72% | 16.47% | 13.91% |
Income Tax | -313.46M | 122.5M | 486.35M | 168.68M | 683.96M | -48.21M | 552.62M | 790.29M | 580.3M | 486.32M |
Effective Tax Rate % | -359.08% | -1559.49% | 21.28% | 16.86% | 21.85% | 31.81% | 20.82% | 21.73% | 21.24% | 21.1% |
Net Income | 395.27M▲ 0% | -128.18M▼ 132.4% | 1.79B▲ 1496.8% | 816.03M▼ 54.4% | 2.42B▲ 196.9% | -216.28M▼ 108.9% | 2B▲ 1022.9% | 2.75B▲ 37.6% | 2.11B▼ 23.3% | 1.77B▲ 0% |
Net Margin % | 6.52% | -1.84% | 18.81% | 8.47% | 18.76% | -1.83% | 12.7% | 16.4% | 12.7% | 10.7% |
Net Income Growth % | -13.26% | -132.43% | 1496.84% | -54.42% | 196.94% | -108.93% | 1022.92% | 37.62% | -23.3% | -3.83% |
EPS (Diluted) | 25.81▲ 0% | -9.21▼ 135.7% | 129.07▲ 1501.4% | 55.63▼ 56.9% | 176.51▲ 217.3% | -23.72▼ 113.4% | 146.98▲ 719.6% | 199.32▲ 35.6% | 169.22▼ 15.1% | 157.85▲ 0% |
EPS Growth % | -17.46% | -135.68% | 1501.41% | -56.9% | 217.29% | -113.44% | 719.65% | 35.61% | -15.1% | 2.27% |
EPS (Basic) | 25.89 | -9.21 | 129.25 | 55.67 | 176.92 | -23.72 | 147.32 | 199.69 | 169.74 | - |
Diluted Shares Outstanding | 14.01M | 13.92M | 13.88M | 13.82M | 13.8M | 13.58M | 13.38M | 13.04M | 12.73M | 11.23M |
MKL Balance Sheet
Markel Corporation (MKL) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 27.39B | 27.2B | 30.63B | 34.27B | 48.48B | 49.79B | 43.44B | 47.35B | 68.91B | 68.6B |
Asset Growth % | 13.37% | -0.7% | 12.58% | 11.9% | 41.46% | 2.71% | -12.75% | 8.98% | 45.54% | 98.73% |
Total Investment Assets | 18.07B | 16.84B | 18.76B | 19.71B | 23.41B | 22.2B | 27.13B | 30.92B | 32.84B | 4M |
Long-Term Investments | 18.07B | 16.84B | 18.76B | 19.71B | 9.02B | 7.67B | 27.13B | 30.92B | 25.77B | 114.02B |
Short-Term Investments | 0 | 0 | 0 | 0 | 14.39B | 14.53B | 0 | 0 | 7.07B | 7.18B |
Total Current Assets | 3.82B | 3.72B | 4.93B | 7.15B | 30.77B | 33.22B | 6.96B | 7.06B | 33.32B | 33.64B |
Cash & Equivalents | 2.5B | 2.4B | 3.5B | 5.22B | 3.98B | 4.14B | 4.33B | 4.19B | 3.96B | 3.68B |
Receivables | 1.32B | 1.33B | 1.42B | 1.93B | 9.71B | 11.41B | 2.63B | 2.87B | 18.58B | 46.41B |
Other Current Assets | 6.58B | 5.59B | 6.88B | 9.6B | 902.46M | 1.08B | 0 | 0 | 638.6M | 500.82M |
Goodwill & Intangibles | 3.13B | 3.96B | 4.05B | 4.39B | 5.52B | 5.31B | 4.21B | 4.2B | 5.27B | 19.3B |
Goodwill | 1.78B | 2.24B | 2.31B | 2.6B | 2.9B | 2.64B | 2.62B | 2.74B | 2.82B | 2.84B |
Intangible Assets | 1.36B | 1.73B | 1.74B | 1.78B | 2.62B | 2.67B | 1.59B | 1.46B | 2.45B | 2.36B |
PP&E (Net) | 501.62M | 551.54M | 821.32M | 1.16B | 0 | 0 | 1.93B | 2.08B | 0 | 0 |
Other Assets | 1.43B | 1.67B | 2.05B | 1.86B | 3.16B | 3.59B | 3.19B | 3.05B | 4.54B | 4.68B |
Total Liabilities | 17.73B | 17.93B | 19.37B | 21.21B | 33.28B | 36.05B | 27.92B | 29.88B | 49.8B | 49.95B |
Total Debt | 3.1B | 3.01B | 4.01B | 4.52B | 4.82B | 4.1B | 4.97B | 5.65B | 4.3B | 4.38B |
Net Debt | 598.38M | 613.14M | 508.58M | -692.44M | 844.15M | -33.8M | 636.35M | 1.45B | 339.11M | 702.38M |
Long-Term Debt | 3.01B | 2.72B | 3.68B | 3.92B | 4.82B | 3.85B | 4.24B | 4.88B | 4.3B | 4.38B |
Short-Term Debt | 86.31M | 288.54M | 113.05M | 126.8M | 0 | 249.94M | 202M | 172.79M | 0 | 0 |
Total Current Liabilities | 4.94B | 5.4B | 0 | 0 | 24.18B | 28.09B | 0 | 0 | 39.78B | 40.22B |
Accounts Payable | 4.94B | 5.4B | 5.66B | 6.23B | 7.49B | 669.74M | 1.04B | 1.43B | 1.67B | 16.35B |
Deferred Revenue | 0 | 0 | 2.64B | 2.98B | 5.38B | 6.22B | 6.64B | 7.06B | 7.25B | 7.23B |
Other Current Liabilities | -5.03B | -5.69B | -8.42B | -9.34B | 11.3B | 20.95B | -7.88B | -8.67B | 30.86B | 16.64B |
Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 0 | 0 |
Other Liabilities | 13.77B | 14.31B | 14.59B | 15.82B | 4.27B | 4.11B | 21.95B | 22.8B | 5.72B | 5.35B |
Total Equity | 9.67B▲ 0% | 9.27B▼ 4.1% | 11.26B▲ 21.4% | 13.06B▲ 16.0% | 15.2B▲ 16.4% | 13.74B▼ 9.6% | 15.53B▲ 13.0% | 17.47B▲ 12.5% | 19.1B▲ 9.3% | 18.65B▲ 0% |
Equity Growth % | 13.19% | -4.07% | 21.37% | 16.03% | 16.4% | -9.63% | 13.02% | 12.52% | 9.35% | 28.52% |
Shareholders Equity | 9.5B | 9.08B | 11.07B | 12.8B | 14.72B | 13.15B | 14.98B | 16.92B | 18.6B | 18.13B |
Minority Interest | 163.7M | 193.71M | 185.11M | 260.53M | 484.24M | 585.95M | 541.97M | 553.08M | 504.43M | 518.12M |
Retained Earnings | 3.78B | 5.78B | 7.46B | 8.2B | 10.45B | 9.83B | 11.35B | 13.38B | 15.03B | 14.66B |
Common Stock | 3.38B | 3.39B | 3.4B | 3.43B | 3.44B | 3.49B | 3.52B | 3.56B | 3.67B | 3.71B |
Accumulated OCI | 2.35B | -94.65M | 208.77M | 584.38M | 237.62M | -767.49M | -478.21M | -617.08M | -109.46M | -237.6M |
Return on Equity (ROE) | 4.34% | -1.35% | 17.44% | 6.71% | 17.15% | -1.49% | 13.64% | 16.65% | 11.52% | 9.56% |
Return on Assets (ROA) | 1.53% | -0.47% | 6.19% | 2.51% | 5.86% | -0.44% | 4.28% | 6.05% | 3.62% | 2.98% |
Equity / Assets | 35.29% | 34.09% | 36.75% | 38.11% | 31.36% | 27.59% | 35.74% | 36.9% | 27.72% | 27.19% |
Debt / Equity | 0.32x | 0.32x | 0.36x | 0.35x | 0.32x | 0.30x | 0.32x | 0.32x | 0.23x | 0.24x |
Book Value per Share | 690.26 | 666.12 | 810.89 | 944.83 | 1101.56 | 1011.56 | 1160.55 | 1339.54 | 1500.56 | 1660.37 |
Tangible BV per Share | 466.56 | 381.40 | 519.34 | 627.43 | 701.87 | 620.42 | 845.60 | 1017.83 | 1086.22 | 1198.12 |
MKL Cash Flow Statement
Markel Corporation (MKL) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 858.53M | 892.86M | 1.27B | 1.74B | 2.27B | 2.71B | 2.79B | 2.59B | 2.76B | 2.4B |
Operating CF Growth % | 60.59% | 4% | 42.7% | 36.38% | 30.88% | 19.15% | 2.86% | -6.92% | 6.45% | -37.75% |
Operating CF / Revenue % | 14.16% | 12.85% | 13.38% | 18.03% | 17.6% | 22.94% | 17.74% | 15.49% | 16.64% | 14.49% |
Net Income | 400.76M | -130.35M | 1.8B | 831.77M | 2.45B | -101.2M | 2.1B | 2.85B | 2.11B | 1.77B |
Depreciation & Amortization | 203.87M | 227.85M | 269.24M | 307.07M | 336.39M | 366.95M | 259.92M | 342.36M | 0 | 0 |
Stock-Based Compensation | 11.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | -324.09M | 2.73M | 323.38M | -2.73M | 453.41M | -281.75M | 233.8M | 394.56M | 0 | 0 |
Other Non-Cash Items | 20.85M | -25.17M | -1.55B | -494.68M | -1.88B | 1.53B | -1.41B | -2.06B | -379.35M | 587.55M |
Working Capital Changes | 551.84M | 287.61M | 433.62M | 1.1B | 919.73M | 1.2B | 1.61B | 1.07B | 1.03B | 0 |
Cash from Investing | -744.46M | -797.24M | -535.16M | -511.75M | -2.94B | -1.67B | -2.7B | -2.4B | -1.31B | -1.79B |
Capital Expenditures | -74.65M | -106.59M | -123.38M | -101.3M | -145.25M | -254.71M | -258.62M | -254.99M | 0 | -150.33M |
Acquisitions | -1.44B | -1.18B | -503M | -554.13M | -525.64M | 752.33M | -155M | -207.75M | 0 | -80.16M |
Purchase of Investments | -941.54M | -444.28M | -1.05B | -2.15B | -3.42B | -3.4B | -4.94B | -4.37B | 0 | -2.82B |
Sale/Maturity of Investments | 1.71B | 971.01M | 1.13B | 2.22B | 1.14B | 1.39B | 2.63B | 2.4B | 0 | 2.06B |
Other Investing | 5.57M | -42.16M | 16.8M | 72.93M | 16.21M | -161.09M | 23.08M | 32.17M | -1.31B | -798.63M |
Cash from Financing | 256.31M | -178.99M | 359.32M | 434.56M | 369.77M | -595.31M | -999.72M | -297.88M | -1.09B | -1.12B |
Dividends Paid | 0 | 0 | 0 | -18.4M | -36M | -36M | -36M | -36M | -618M | -618M |
Share Repurchases | -110.84M | -54.01M | -116.31M | -26.83M | -206.52M | -290.8M | -445.48M | -572.73M | -429.52M | -393.18M |
Stock Issued | 552K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debt Issuance (Net) | 1000K | -1000K | 1000K | -1000K | 1000K | -1000K | -1000K | 1000K | -1000K | -1000K |
Other Financing | -37.53M | -42.73M | -65.88M | -59.29M | -99.49M | -47.56M | -193.57M | -226.61M | -9.88M | -155.03M |
Net Change in Cash | 415.68M▲ 0% | -104.41M▼ 125.1% | 1.1B▲ 1157.3% | 1.72B▲ 55.5% | -335.7M▼ 119.6% | 340.57M▲ 201.4% | -889.48M▼ 361.2% | -139.79M▲ 84.3% | 411.05M▲ 394.1% | -493.66M▲ 0% |
Exchange Rate Effect | 45.3M | -21.05M | 5.64M | 55.9M | -41.73M | -103.36M | 27.04M | -37.3M | 49.77M | 30.28M |
Cash at Beginning | 2.09B | 2.5B | 2.4B | 3.5B | 5.22B | 4.88B | 5.22B | 4.33B | 4.19B | 4.6B |
Cash at End | 2.5B | 2.4B | 3.5B | 5.22B | 4.88B | 5.22B | 4.33B | 4.19B | 4.6B | 4.18B |
Free Cash Flow | 783.88M▲ 0% | 786.26M▲ 0.3% | 1.15B▲ 46.4% | 1.64B▲ 42.2% | 2.13B▲ 30.1% | 2.45B▲ 15.3% | 2.53B▲ 3.0% | 2.34B▼ 7.5% | 2.55B▲ 9.2% | 2.19B▲ 0% |
FCF Growth % | 66.45% | 0.3% | 46.36% | 42.19% | 30.1% | 15.31% | 2.99% | -7.48% | 9.21% | 3.39% |
FCF Margin % | 12.93% | 11.31% | 12.09% | 16.98% | 16.48% | 20.78% | 16.09% | 13.96% | 15.4% | 13.2% |
FCF per Share | 55.97 | 56.47 | 82.9 | 118.37 | 154.26 | 180.76 | 188.98 | 179.36 | 200.66 | 194.75 |
MKL Key Ratios
Markel Corporation (MKL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 98.56% | 100.11% | 75.99% | 89.62% | 75.77% | 101.28% | 83.11% | 78.28% | 83.53% | 86.11% |
Medical Cost Ratio | 69.56% | 61.94% | 49.03% | 64.91% | 54.38% | 71.17% | 48.57% | 44.64% | 30.62% | 38.56% |
Return on Equity (ROE) | 4.34% | -1.35% | 17.44% | 6.71% | 17.15% | -1.49% | 13.64% | 16.65% | 11.52% | 9.56% |
Return on Assets (ROA) | 1.53% | -0.47% | 6.19% | 2.51% | 5.86% | -0.44% | 4.28% | 6.05% | 3.62% | 2.98% |
Equity / Assets | 35.29% | 34.09% | 36.75% | 38.11% | 31.36% | 27.59% | 35.74% | 36.9% | 27.72% | 27.19% |
Book Value / Share | 690.26 | 666.12 | 810.89 | 944.83 | 1.1K | 1.01K | 1.16K | 1.34K | 1.5K | 1.66K |
Debt / Equity | 0.32x | 0.32x | 0.36x | 0.35x | 0.32x | 0.30x | 0.32x | 0.32x | 0.23x | 0.24x |
Revenue Growth | 8.09% | 14.59% | 36.98% | 1.26% | 34.02% | -8.55% | 33.02% | 6.6% | -0.96% | 7.74% |
Related:MKL Dividend History·MKL Revenue History·MKL Price History·MKL P/E History·MKL Financial Ratios·MKL Institutional Holders
MKL SEC Filings & Documents
Markel Corporation (MKL) SEC filings — annual & quarterly reports (10-K, 10-Q)
MKL Frequently Asked Questions
Markel Corporation (MKL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Markel Corporation (MKL) saw revenue decline by 1.0% over the past year.
Yes, Markel Corporation (MKL) is profitable, generating $1.77B in net income for fiscal year 2025 (12.7% net margin).
Dividend & Returns
Yes, Markel Corporation (MKL) pays a dividend with a yield of 2.63%. This makes it attractive for income-focused investors.
Markel Corporation (MKL) has a return on equity (ROE) of 11.5%. This is reasonable for most industries.
Industry Metrics
Markel Corporation (MKL) has a combined ratio of 83.5%. A ratio below 100% indicates underwriting profitability.